| 1 |
22356805 | Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts. | 2012 May |
4 |
| 2 |
21241278 | Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma. | 2011 Mar |
1 |
| 3 |
12017294 | Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cells. | 2002 Jan-Feb |
1 |
| 4 |
11236942 | The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro. | 2001 Feb |
2 |
| 5 |
11309322 | Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion. | 2001 Apr |
1 |
| 6 |
7530507 | Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group. | 1995 Feb 1 |
1 |
| 7 |
8492420 | [Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6]. | 1993 Feb |
1 |